Skip to main content

Table 1 Patient and treatment characteristics (n = 22)

From: The efficacy of stereotactic body radiation therapy on huge hepatocellular carcinoma unsuitable for other local modalities

Characteristics Number of patients (%)
Age  
60 y.o. 17(77.3)
 <60 y.o. 5(22.7)
Gender  
 Male 18(81.8)
 Female 4(18.2)
ECOG  
 0 3(13.6)
 1 17(77.3)
 2 2(9.1)
BCLC  
 B 2(9.1)
 C 20(90.9)
Vascular extension (PVTT & IVCTT)  
 Yes 16(72.7)
 No 6(27.3)
Child-Pugh stage  
 A 20(90.9)
 B 2(9.1)
Hepatitis virus  
 B 12(54.5)
 C 4(18.2)
Non B non C 6(27.3)
AFP  
 <1500 15(68.2)
 1500 7(31.8)
Tumor Location  
 Right 21(95.5)
 Left 1(4.5)
Tumor type  
 Solitary 11(50)
 Multiple 8(36.4)
 Diffuse 3(13.6)
Tumor size  
 10 cm 7(31.8)
 >10 cm 15(68.2)
Radiation dose  
 40 Gy 16(72.7)
 < 40 Gy 6(27.3)
Pre-SBRT treatment  
 Yes 9(40.9)
 No 13(59.1)
Post – SBRT treatment  
 Yes 6(27.3)
 No 16(72.7)